#tev408 — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #tev408, aggregated by home.social.
-
Press release - 2 Sept 2026
Teva Announces Positive Topline Results from Phase 2a Study in Celiac Disease for Its Anti-IL-15 Antibody...
TEV'408 is also in Phase 1b testing for the treatment of vitiligo.